>Q9UBT2_Disorder
3-7, 161-179, 205-210, 296-300, 427-444, 564-579, 596-600
maLSRGLpre laeavaggrv lvvgaggigc ellknlvltg fshidlidld tidvsnlnrq flfqkkhvgr skaqvakesv lqfypkaniv ayhdsimnpd ynveffrqfi lvmnaldnra arnhvnrmcl aadvpliesg tagylgqvtt ikkgvtecye CHPKPTQRTF PGCTIRNTPs epihcivwak ylfnqlfgee dadqEVSPDR adpeaawept eaeararasn edgdikrist kewakstgyd pvklftklfk ddirylltmd klwrkrkppv pldwaevqsq geetnASDQQ nepqlglkdq qvldvksyar lfsksietlr vhlaekgdga eliwdkddps amdfvtsaan lrmhifsmnm ksrfdiksma gniipaiatt naviaglivl eglkilsgki dqcrtiflnk qpnprkKLLV PCALDPPNPN CYVCaskpev tvrlnvhkvt vltlqdkivk ekfamvapdv qiedgkgtil isseegetea nnhkklsefg irngsrlqad dflqdytlli nilhsedlgk dvefevvgda pekvgpkqae daaKSITNGS DDGAQPSTSt aqeqddvliv dsdeeDSSNN advseeersr krkldekenl sakrsrieqk eelddviald
>Q9UBT2_GlobDoms
1-160, 180-426, 445-563
MALSRGLPRE LAEAVAGGRV LVVGAGGIGC ELLKNLVLTG FSHIDLIDLD TIDVSNLNRQ FLFQKKHVGR SKAQVAKESV LQFYPKANIV AYHDSIMNPD YNVEFFRQFI LVMNALDNRA ARNHVNRMCL AADVPLIESG TAGYLGQVTT IKKGVTECYE chpkptqrtf pgctirntpS EPIHCIVWAK YLFNQLFGEE DADQEVSPDR ADPEAAWEPT EAEARARASN EDGDIKRIST KEWAKSTGYD PVKLFTKLFK DDIRYLLTMD KLWRKRKPPV PLDWAEVQSQ GEETNASDQQ NEPQLGLKDQ QVLDVKSYAR LFSKSIETLR VHLAEKGDGA ELIWDKDDPS AMDFVTSAAN LRMHIFSMNM KSRFDIKSMA GNIIPAIATT NAVIAGLIVL EGLKILSGKI DQCRTIFLNK QPNPRKkllv pcaldppnpn cyvcASKPEV TVRLNVHKVT VLTLQDKIVK EKFAMVAPDV QIEDGKGTIL ISSEEGETEA NNHKKLSEFG IRNGSRLQAD DFLQDYTLLI NILHSEDLGK DVEFEVVGDA PEKVGPKQAE DAAksitngs ddgaqpstst aqeqddvliv dsdeedssnn advseeersr krkldekenl sakrsrieqk eelddviald
JOB-ID: | Q9UBT2_091430ZgU09n8AAAEAAFUHizAAAAAO |
---|---|
Paramters: | propensities=Russell/Linding smooth=10 dy/dx_smooth=10 |
Disorder frames: | peak-frame=5 join-frame=4 |
Globularity frames: | peak-frame=74 join-frame=15 |
Name: | Q9UBT2 |
Description: | sp|Q9UBT2|SAE2_HUMAN SUMO-activating enzyme subunit 2 OS=Homo sapiens OX=9606 GN=UBA2 PE=1 SV=2 |
Plot title/ID: | none |
Sequence length: | 640 |
Download Results | smoothed raw dydx |